Is it time to measure microalbuminuria in hypertension?

Massimo Volpe, Francesco Cosentino, Luis M. Ruilope

Research output: Contribution to journalArticlepeer-review


Former guidelines on hypertension never made a commitment to the detection of microalbuminuria for screening or follow-up of hypertensive patients. On the other hand, growing evidence support the contributory role of microalbuminuria in the prediction of absolute cardiovascular risk in hypertension and document the potential relevance of this parameter to the initial choice of antihypertensive treatment. Upcoming new guidelines and diagnostic algorithms in hypertension need to underscore the clinical positioning of microalbuminuria for stratification of risk and follow-up purposes.

Original languageEnglish
Pages (from-to)1213-1220
Number of pages8
JournalJournal of Hypertension
Issue number7
Publication statusPublished - Jul 1 2003


  • Angiotensin receptor antagonists
  • Angiotensin-converting enzyme inhibition
  • Cardiovascular disease
  • Microalbuminuria
  • Proteinuria
  • Renal function

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology


Dive into the research topics of 'Is it time to measure microalbuminuria in hypertension?'. Together they form a unique fingerprint.

Cite this